Advanced search
Publication Cover
Acta Cardiologica Volume 78, 2023 - Issue 5
Submit an article Journal homepage
27
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Comment on ‘Optimisation of individual cardiovascular risk assessment using a commercial test for genetic polymorphisms’

Rujittika Mungmunpuntipantipa Private Academic Consultant, Bangkok, ThailandCorrespondence[email protected]
&
Viroj Wiwanitkitb Department of Pharmaceutical Sciences, University Centre for Research & Development, Chandigarh University Gharuan, Mohali, Punjab, India
Page 634 | Received 03 Oct 2022, Accepted 06 Oct 2022, Published online: 07 Nov 2022

References

  • Krohn JB, Neubauer C, Fischer S, et al. Optimisation of individual cardiovascular risk assessment in a German coronary artery disease cohort using a commercial test for genetic polymorphisms – a pilot study. Acta Cardiol. 2022;3:1–11.
  • Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014;211(5):527.e1–527.e17.
  • Liehr T. Non-invasive prenatal testing, what patients do not learn, may be due to lack of specialist genetic training by gynecologists and obstetricians? Front Genet. 2021;12:682980.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.